HC
Health Catalyst, Inc.
HCAT · NASDAQ
$1.76 +0.57% (+$0.01)
1M +2.94%
Market Cap $130.1M
P/E Ratio -
Div. Yield -
ROE 129.71%
Bulios Fair Price
$2.24
27.3% upside
Trenutna cena
$1.76
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica HCAT trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Moderate
5/9Valuation
100 /100
Cheap P/S 0.45x
P/B 1.29x
P/FCF 9.96x
Growth
31 /100
Declining Rev. growth 4.05%
Book val. growth 16.69%
EPS growth N/A
Profitability
29 /100
Weak Gross margin 46.44%
Net margin 90.61%
FCF margin 4.47%
Quality
10 /100
Poor ROIC 21.22%
ROE 129.71%
Asset turnover 0.81x
Debt
36 /100
Moderate Debt/Equity 1.69x
Current ratio 2.70x
Int. coverage -12.06x
Stability
39 /100
Moderate Beta 1.53x
Rev. volatility 2.85%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o HCAT
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Benjamin Albert
Employees
1,200
Headquarters
South Jordan
Prihajajoči dogodki
09 NOV.
Earnings
Upcoming earnings report